Showing results (451-460 of 487) with videos related to

Sort By:
Pageof 49
The Journal of Organic Chemistry|March 2, 2002
Synthesis and NMR studies of (13)C-labeled vitamin D metabolitesWilliam H Okamura, Gui-Dong Zhu, David K Hill, et al.
Steroids|April 19, 2002
Molecular tools for study of genomic and rapid signal transduction responses initiated by 1 alpha,25(OH)(2)-vitamin D(3)Anthony W Norman, June E Bishop, Craig M Bula, et al.
The Journal of Biological Chemistry|January 27, 2005
Nongenotropic, anti-apoptotic signaling of 1alpha,25(OH)2-vitamin D3 and analogs through the ligand binding domain of the vitamin D receptor in osteoblasts and osteocytes. Mediation by Src, phosphatidylinositol 3-, and JNK kinasesAnthony M Vertino, Craig M Bula, Jin-Ran Chen, et al.
Steroids|February 22, 2002
Evidence for distinct membrane receptors for 1 alpha,25-(OH)(2)D(3) and 24R,25-(OH)(2)D(3) in osteoblastsBarbara D Boyan, Lynda F Bonewald, Victor L Sylvia, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 8, 2011
1α,25(OH)₂-vitamin D and a nongenomic vitamin D analogue inhibit ultraviolet radiation-induced skin carcinogenesisKatie M Dixon, Anthony W Norman, Vanessa B Sequeira, et al.
Journal of the American Chemical Society|May 6, 2008
Bidentates versus monodentates in asymmetric hydrogenation catalysis: synergic effects on rate and allosteric effects on enantioselectivityDavid W Norman, Charles A Carraz, David J Hyett, et al.
The Journal of Urology|November 13, 2007
Levels of 5alpha-reductase type 1 and type 2 are increased in localized high grade compared to low grade prostate cancerLynn N Thomas, Robert C Douglas, Catherine B Lazier, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|August 1, 2019
Celebrating 75 yearsDarren Beiko, R John D'A Honey, Kenneth T Pace, et al.
The American Journal of Medicine|March 1, 1983
Preliminary trials with 24,25-dihydroxyvitamin D3 in dialysis osteomalaciaA B Hodsman, E G Wong, D J Sherrard, et al.
The Journal of Biological Chemistry|September 25, 1993
Demonstration that 1 beta,25-dihydroxyvitamin D3 is an antagonist of the nongenomic but not genomic biological responses and biological profile of the three A-ring diastereomers of 1 alpha,25-dihydroxyvitamin D3A W Norman, R Bouillon, M C Farach-Carson, et al.
Pageof 49